School of Tropical Medicine News

Dr. María Elena Bottazzi honored for work on Chagas vaccineJun 5, 2018
The Latin American nonprofit Fundación Carlos Slim has awarded Dr. María Elena Bottazzi the 2018 Research Trajectory Slim Health Award for her 20-year work developing vaccines for parasitic diseases.
Hotez, Zoghbi join American Academy of Arts and SciencesApr 18, 2018
Dr. Peter J. Hotez, and Dr. Huda Y. Zoghbi have been elected as the newest members of the American Academy of Arts and Sciences, one of the nation’s most prestigious honorary titles.
Hotez joins U.S.-Israel Binational Science Foundation boardFeb 8, 2018
Dr. Peter Hotez was appointed as a representative to the U.S.-Israel Binational Science Foundation Board of Governors. 
Schistosoma vaccine to enter Phase Ib clinical trialJan 18, 2018
Researchers have received funding from the National Institutes of Health for a Phase Ib clinical trial for a Schistosomiasis vaccine in an endemic area of Brazil.
DoD funds cutaneous leishmaniasis vaccine development Sep 27, 2017
The National School of Tropical Medicine has received a $1.3 million contract from the Department of Defense to develop a vaccine for cutaneous leishmaniasis.
Hookworms, poverty, poor sanitation linked in rural AlabamaSep 6, 2017
Problems with poor sanitation linked to extreme poverty also have resulted in a recurrence or persistence of hookworm infection in rural areas of Alabama
Baylor recruiting volunteers for chikungunya vaccine trialAug 23, 2017
Researchers at Baylor College of Medicine are recruiting volunteers for a vaccine trial to test the safety and immune responses to a vaccine against chikungunya virus.
Low vaccination rates in U.S. have economic, public health impact Jul 24, 2017
Examining case examples, researchers find even a small decline in vaccination rates across the United States could have significant public health and economic consequences.
Grant funds continued research for river blindness vaccine Jun 21, 2017
The grant will support the continuation of the international initiative TOVA – The Onchocerciasis Vaccine for Africa – which was established in 2015 and is comprised of 13 world-renowned scientists and research centers.
Chikungunya vaccine trial underway at BaylorJun 5, 2017
The National Institutes of Health-funded Vaccine and Treatment Evaluation Unit at Baylor will be one of the sites for a clinical trial testing the safety and immune responses to a vaccine against chikungunya virus.